Metraipolis › archive › dc_fedccded16f3

Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and… — Europe PMC PMID:41625236

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41625236
DOI: 10.3389/fendo.2025.1734549
License (as archived): solo-consultazione
Archived: 2026-11-06T18:54:29.487Z
SHA-256 of the archived text: 13bf764efa280fd4d26ec7320fc591b1be49c95e68375b5ba2dd43913a9aff85
Stable URL of this page: https://metraipolis.com/documento/dc_fedccded16f3

How to cite

Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and… — Europe PMC PMID:41625236 — Europe PMC (en), https://europepmc.org/article/MED/41625236 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fedccded16f3 (Metraipolis archive dc_fedccded16f3, sha256 13bf764efa280fd4d26ec7320fc591b1be49c95e68375b5ba2dd43913a9aff85)

BibTeX

@misc{dcfedccded16f3,
  title = {Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and… — Europe PMC PMID:41625236},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41625236},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fedccded16f3; sha256 13bf764efa280fd4d26ec7320fc591b1be49c95e68375b5ba2dd43913a9aff85},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41625236. Agents can read the archived copy with the MCP tool read_document.